share_log
Reuters ·  Jan 29 13:30
Immunitybio Announces Collaboration With Beigene on Confirmatory Phase 3 Trial of Anktiva® and Pd-1 Checkpoint Inhibitor Combination in Non-Small Cell Lung Cancer
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 412

Recommended

Write a comment